Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China
· Delayed Price · Currency is CNY 16.71
-0.10 (-0.59%)
Apr 30, 2026, 2:55 PM CST
SHE:002393 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 412.89 | 416.28 | 184.53 | 361.83 | 93.61 | 122.11 | Upgrade
|
| Depreciation & Amortization | 77.71 | 77.71 | 81.17 | 67.31 | 66.12 | 60.2 | Upgrade
|
| Other Amortization | 2.39 | 2.39 | 0.03 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.25 | -0.25 | 0.05 | -238.7 | 34.82 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.12 | 4.12 | 0.37 | 15.27 | 1.2 | 1.61 | Upgrade
|
| Loss (Gain) From Sale of Investments | -326.75 | -326.75 | -102.84 | -15.97 | -23.96 | -19.25 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.02 | 0.02 | 0 | - | - | - | Upgrade
|
| Other Operating Activities | 29.97 | 24.61 | 19.11 | 14.11 | 19 | 14.08 | Upgrade
|
| Change in Accounts Receivable | 78.87 | 78.87 | -42.56 | 17.52 | 25.13 | -19.5 | Upgrade
|
| Change in Inventory | 11.28 | 11.28 | -21.72 | 8.91 | 11.14 | -4.35 | Upgrade
|
| Change in Accounts Payable | -30.47 | -30.47 | -31.66 | -28.28 | 116.95 | 50.22 | Upgrade
|
| Change in Other Net Operating Assets | 15.87 | 15.87 | 5.55 | 3.49 | 2.74 | -0.03 | Upgrade
|
| Operating Cash Flow | 249.46 | 247.5 | 88.26 | 200.01 | 331.38 | 196.34 | Upgrade
|
| Operating Cash Flow Growth | 3541.44% | 180.41% | -55.87% | -39.65% | 68.78% | 157.09% | Upgrade
|
| Capital Expenditures | -34.76 | -37.46 | -53.75 | -61.72 | -40.91 | -88.24 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.9 | 2.93 | 0.41 | 253.54 | 115.27 | 0.09 | Upgrade
|
| Cash Acquisitions | -6.99 | -6.99 | - | -102 | - | - | Upgrade
|
| Investment in Securities | -401.25 | -330.11 | -262.61 | -79.96 | -250.04 | - | Upgrade
|
| Other Investing Activities | 201.67 | 204.34 | 56.86 | 9.5 | 20.04 | 12.04 | Upgrade
|
| Investing Cash Flow | -238.42 | -167.29 | -259.09 | 19.36 | -155.64 | -76.12 | Upgrade
|
| Short-Term Debt Issued | - | 24.31 | 39.75 | - | - | - | Upgrade
|
| Total Debt Issued | 24.31 | 24.31 | 39.75 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -39.75 | -47.19 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -2.37 | -6.04 | -0.3 | -0.06 | - | Upgrade
|
| Total Debt Repaid | -32.87 | -42.12 | -53.24 | -0.3 | -0.06 | - | Upgrade
|
| Net Debt Issued (Repaid) | -8.56 | -17.81 | -13.49 | -0.3 | -0.06 | - | Upgrade
|
| Issuance of Common Stock | 7.58 | 68.68 | - | 5.55 | 21.01 | - | Upgrade
|
| Repurchase of Common Stock | -93.06 | -93.06 | -39.59 | - | - | - | Upgrade
|
| Common Dividends Paid | -173.06 | -97 | -121.03 | -54.74 | -54.74 | -18.25 | Upgrade
|
| Other Financing Activities | 94.34 | 1.05 | -0.07 | 0.67 | - | - | Upgrade
|
| Financing Cash Flow | -172.76 | -138.14 | -174.18 | -48.82 | -33.79 | -18.25 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | -0 | 0 | - | - | - | Upgrade
|
| Net Cash Flow | -161.72 | -57.93 | -345 | 170.54 | 141.95 | 101.97 | Upgrade
|
| Free Cash Flow | 214.7 | 210.04 | 34.51 | 138.29 | 290.47 | 108.1 | Upgrade
|
| Free Cash Flow Growth | - | 508.58% | -75.04% | -52.39% | 168.71% | - | Upgrade
|
| Free Cash Flow Margin | 15.85% | 15.09% | 2.58% | 11.99% | 25.33% | 9.90% | Upgrade
|
| Free Cash Flow Per Share | 0.70 | 0.68 | 0.11 | 0.45 | 0.94 | 0.35 | Upgrade
|
| Cash Income Tax Paid | 190.27 | 190.18 | 154.11 | 195.53 | 133.17 | 126.12 | Upgrade
|
| Levered Free Cash Flow | 271.09 | 48.92 | 88.16 | 24.69 | 302.3 | 8.51 | Upgrade
|
| Unlevered Free Cash Flow | 272.49 | 50.33 | 89.82 | 25.16 | 302.85 | 8.71 | Upgrade
|
| Change in Working Capital | 49.36 | 49.36 | -94.16 | -3.83 | 140.6 | 17.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.